C.M. Bidwell & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,278
Closed -$328K – 570
2021
Q4
$328K Sell
1,278
-77
-6% -$18.8K 0.2% 82
2021
Q3
$329K Sell
1,355
-38
-3% -$9.29K 0.22% 75
2021
Q2
$288K Buy
+1,393
New +$284K 0.19% 94
2017
Q4
– Sell
-26
Closed -$2K – 416
2017
Q3
$2K Hold
26
– – ﹤0.01% 271
2017
Q2
$2K Buy
+26
New +$2.2K ﹤0.01% 284
2016
Q3
– Sell
-51,765
Closed -$3.99M – 287
2016
Q2
$3.99M Hold
51,765
– – 0.99% 34
2016
Q1
$4.04M Buy
+51,765
New +$3.61M 1.01% 27
2015
Q4
– Sell
-50,080
Closed -$3.87M – 251
2015
Q3
$3.87M Buy
50,080
+6,335
+14% +$561K 0.95% 46
2015
Q2
$3.97M Buy
+43,745
New +$3.5M 0.89% 52
2014
Q3
– Sell
-66,600
Closed -$3.75M – 252
2014
Q2
$3.75M Sell
66,600
-4,695
-7% -$248K 0.86% 61
2014
Q1
$3.74M Buy
+71,295
New +$3.55M 0.9% 54

Other funds holding HCA

C.M. Bidwell & Associates's HCA Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 1,278 shares — an estimated $328K sold.

C.M. Bidwell & Associates first reported a position in HCA in Q1 2014 and held it in 11 quarters. The position peaked at $4.04M in Q1 2016. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,278 HCA Healthcare shares in Q1 2022, an estimated $328K.
  • C.M. Bidwell & Associates first reported a position in HCA Healthcare in Q1 2014 and held it in 11 quarters.
  • C.M. Bidwell & Associates's HCA Healthcare position peaked at $4.04M in Q1 2016.
  • 968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.